Sandeep Gurbuxani to Protein Kinase Inhibitors
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Protein Kinase Inhibitors.
Connection Strength
0.146
-
AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia. 2013 Sep; 27(9):1882-90.
Score: 0.081
-
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239.
Score: 0.041
-
Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med. 2015 Dec; 21(12):1473-80.
Score: 0.024